Not Tagged
arcellx
['multiple myeloma', 'cart,(-cartitude)', 'arcellx', '$aclx']
$aclx arcellx presents continued robust long-term responses from its cart-ddbcma phase 1 expansion trial in patients with relapsed or refractory multiple myeloma at the 2022 asco annual meeting 